• Men Ages 40-49 Could Skip Annual PSA Screening

Three-fourths of men ages 40–49 could safely avoid annual prostate-specific antigen (PSA) screening for an additional 10 years if their baseline PSA falls in the lowest 75th percentile.  

Mayo Clinic study looked at prostate outcomes in a random sample of 268 men, ages 40–49, in Olmsted County, Minn., since 1990. Each patient was evaluated by a urologist every two years, including PSA screening, an ultrasound examination and questionnaire. Among study participants, no one between 40 and 49 with a baseline PSA below 1 ng/ml developed an intermediate- or high-risk cancer during nearly 20 years of follow-up. The study also found that participants with low PSAs, below 1.0 ng/ml, were also very unlikely to develop even low-risk prostate cancer.  

Soundbites with lead author Mayo Clinic urologist Christopher Weight, M.D., are available in the downloads above.

Expert title for broadcast cg: Dr. Chistopher Weight, Mayo Clinic Urologist

Attention Journalists: Mayo Clinic urologists are presenting findings this week at the American Urological Association Annual Meeting, including several embargoed studies regarding prostate cancer and kidney stones.

Click here for news release. 

Related articles